ENVA NYSE Personal Credit Institutions Financials FY2016βFY2025
Enova International, Inc. had $3.2B of revenue in fiscal 2025, up 18.6% on the year before. Over five years, revenue changed +23.8% a year on average.
Last close Β· Oct 23, 2026
$165.07
6.6%Hi! I read Enova International, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+18.6%
Yes. Sales grew 18.6% last year.
Does it make a profit?
9.8%
A little. It keeps 9.8% of every sale as profit.
Does profit turn into cash?
56.2%
Yes. 56.2% of sales ends up as free cash.
Is debt under control?
5.7x
Heavy. Repaying its debt would take 5.7 years of operating profit.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
11.4x
One share costs 11.4 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Enova International, Inc. had $3.2B of revenue in fiscal 2025, up 18.6% on the year before. Over five years, revenue changed +23.8% a year on average. Its operating margin was 23.5%, up 1.5Β pts: of every 100 in sales, about 23 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Enova International, Inc. made $308M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 30.8% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $1.8B in fiscal 2025, 56.2% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· Enova International, Inc. returned $215M to shareholders in fiscal 2025, 12% of free cash flow. The diluted share count fell 5.1%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders sold $59.4M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$59.4M
7 insiders
Of sales under plans
48%
$28.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | David FisherExecutive Chairman, Director | Sold plan | 20,750 | $178.24 | $3.7M | Form 4 |
| Aug 26, 2026 | David FisherExecutive Chairman, Director | Sold plan | 9,078 | $239.16 | $2.2M | Form 4 |
| Aug 25, 2026 | David FisherExecutive Chairman, Director | Sold plan | 9,491 | $244.01 | $2.3M | Form 4 |
| Jul 15, 2026 | David FisherExecutive Chairman, Director | Sold plan | 11,494 | $231.45 | $2.7M | Form 4 |
| Jul 14, 2026 | David FisherExecutive Chairman, Director | Sold plan | 17,006 | $231.51 | $3.9M | Form 4 |
| Jun 18, 2026 | Mark TebbeDirector | Sold | 20,000 | $201.37 | $4.0M | Form 4 |
| Jun 17, 2026 | David FisherExecutive Chairman, Director | Sold plan | 33,060 | $199.05 | $6.6M | Form 4 |
| Jun 16, 2026 | William M GoodyearDirector | Sold | 3,500 | $188.02 | $0.7M | Form 4 |
| Jun 1, 2026 | William M GoodyearDirector | Sold | 5,983 | $163.13 | $1.0M | Form 4 |
| May 29, 2026 | Linda Johnson RiceDirector | Sold | 1,300 | $161.20 | $0.2M | Form 4 |
| May 22, 2026 | David FisherExecutive Chairman, Director | Sold plan | 3,076 | $158.45 | $0.5M | Form 4 |
| May 21, 2026 | David FisherExecutive Chairman, Director | Sold plan | 7,180 | $160.37 | $1.2M | Form 4 |
| May 18, 2026 | William M GoodyearDirector | Sold | 6,231 | $166.08 | $1.0M | Form 4 |
| May 7, 2026 | David FisherExecutive Chairman, Director | Sold | 20,000 | $173.18 | $3.5M | Form 4 |
| Apr 28, 2026 | Steven E CunninghamChief Executive Officer, Director | Sold | 7,852 | $175.50 | $1.4M | Form 4 |
| Feb 18, 2026 | David FisherExecutive Chairman, Director | Sold plan | 7,143 | $149.49 | $1.1M | Form 4 |
| Feb 2, 2026 | Mark TebbeDirector | Sold | 20,000 | $172.24 | $3.4M | Form 4 |
| Feb 2, 2026 | James A GrayDirector | Sold | 19,999 | $172.04 | $3.4M | Form 4 |
| Jan 30, 2026 | Sean RahillyGeneral Counsel and Secretary | Sold | 12,879 | $164.28 | $2.1M | Form 4 |
| Jan 30, 2026 | Steven E CunninghamChief Executive Officer, Director | Sold | 11,436 | $165.13 | $1.9M | Form 4 |
| Jan 30, 2026 | David FisherExecutive Chairman, Director | Sold | 37,989 | $165.32 | $6.3M | Form 4 |
| Jan 26, 2026 | David FisherExecutive Chairman, Director | Sold plan | 9,573 | $157.81 | $1.5M | Form 4 |
| Dec 16, 2025 | David FisherChief Executive Officer, Director | Sold plan | 15,000 | $160.24 | $2.4M | Form 4 |
| Nov 21, 2025 | David FisherChief Executive Officer, Director | Sold plan | 6,000 | $124.25 | $0.7M | Form 4 |
| Oct 29, 2025 | Steven E CunninghamChief Financial Officer, Director | Sold | 14,874 | $120.70 | $1.8M | Form 4 |
| Oct 27, 2025 | David FisherChief Executive Officer, Director | Sold plan | 6,000 | $122.61 | $0.7M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· Enova International, Inc. owes $4.4B more than it holds in cash, about 5.7 years of operating profit.
Cash, debt and the ratios that show how comfortably Enova International, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $165M | $100M | $54.4M | $73.9M | $71.7M |
| Debt incl. finance leases | $1.4B | $2.3B | $2.9B | $3.6B | $4.5B |
| Net debt / EBITDA | 2.7x | 5.1x | 6.3x | 5.6x | 5.7x |
| Debt / equity | 1.3x | 1.9x | 2.4x | 3.0x | 3.4x |
| Interest coverage | 5.4x | 3.3x | 2.2x | 2.0x | 2.2x |
| Total assets | $2.8B | $3.8B | $4.6B | $5.3B | $6.5B |
| Total liabilities | $1.7B | $2.6B | $3.3B | $4.1B | $5.1B |
| Shareholders' equity | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B |
| Net debt (β = net cash) | $1.2B | $2.2B | $2.9B | $3.5B | $4.4B |
KIRA Β· Its return on capital was 9.9%: every 100 invested in the business earned about 10 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Enova International, Inc. passes 6 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 6 / 8 | 7 / 8 | 7 / 8 | 4 / 8 | 5 / 8 | 5 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | β36.7% | β39.1% | β49.3% | β55.8% | β19.7% | β8.9% | β21.0% | β23.7% | β27.0% | β25.7% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $746M | $729M | $973M | $1.2B | $1.1B | $1.2B | $1.7B | $2.1B | $2.7B | $3.2B |
| Net interest income | β$65.6M | β$74.0M | β$79.4M | β$75.6M | β | β | β | β | β | β |
| Gross profit | $418M | $375M | $469M | $572M | $684M | $1.0B | $1.1B | $1.2B | $1.5B | $1.8B |
| Operating income | $121M | $116M | $176M | $248M | $358M | $413M | $384M | $422M | $585M | $739M |
| Interest expense | β | β | $79.4M | $75.6M | $86.7M | $76.5M | $116M | $195M | $290M | $339M |
| Pretax income | $57.4M | $19.7M | $68.9M | $170M | $435M | $337M | $273M | $227M | $271M | $401M |
| Income tax | $22.8M | $2.1M | $5.3M | $42.1M | $57.2M | $80.1M | $65.2M | $52.1M | $61.7M | $92.6M |
| Net income | $34.6M | $29.2M | $70.1M | $36.6M | $378M | $256M | $207M | $175M | $209M | $308M |
| Diluted EPS | $1.03 | $0.86 | $1.99 | $1.06 | $11.70 | $6.79 | $6.19 | $5.49 | $7.43 | $11.52 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.03B | 0.03B | 0.04B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $393M | $447M | $685M | $849M | $741M | $472M | $894M | $1.2B | $1.5B | $1.8B |
| Capital expenditure | $14.4M | $15.2M | $14.7M | $20.1M | $29.5M | $29.7M | $43.6M | $45.2M | $43.4M | $47.1M |
| Free cash flow | $379M | $432M | $670M | $829M | $711M | $442M | $850M | $1.1B | $1.5B | $1.8B |
| Depreciation and amortization | $15.6M | $13.3M | $14.2M | $15.1M | $19.7M | $35.4M | $36.9M | $38.2M | $40.2M | $41.8M |
| Stock-based compensation | $8.5M | $11.3M | $11.7M | $12.0M | $18.0M | $21.2M | $22.0M | $26.7M | $31.8M | $33.1M |
| Acquisitions | β | β | β | β | β$110M | $29.2M | β | β | β | β |
| Share buybacks | $0.4M | $5.1M | $17.3M | $33.8M | $56.4M | $117M | $143M | $153M | $289M | $215M |
| Dividends and buybacks | $0.4M | $5.1M | $17.3M | $33.8M | $56.4M | $117M | $143M | $153M | $289M | $215M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $39.9M | $49.8M | $28.1M | $35.9M | $297M | $165M | $100M | $54.4M | $73.9M | $71.7M |
| Total debt | $650M | $789M | $858M | $991M | $946M | $1.4B | $2.3B | $2.9B | $3.6B | $4.5B |
| Loans, net | $562M | $705M | $780M | $1.1B | β | β | β | β | β | β |
| Property and equipment, net | $47.1M | $48.5M | $46.1M | $54.5M | $79.4M | $78.4M | $93.2M | $109M | $120M | $133M |
| Goodwill | $267M | $267M | $267M | $267M | $268M | $279M | $279M | $279M | $279M | $279M |
| Intangible assets | $5.4M | $4.3M | $3.3M | $2.2M | $26.0M | $35.4M | $27.4M | $19.0M | $11.0M | $3.7M |
| Total assets | $978M | $1.2B | $1.3B | $1.6B | $2.1B | $2.8B | $3.8B | $4.6B | $5.3B | $6.5B |
| Total liabilities | $736M | $878M | $987M | $1.2B | $1.2B | $1.7B | $2.6B | $3.3B | $4.1B | $5.1B |
| Preferred stock | β | β | β | β | β | β | β | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $242M | $282M | $348M | $377M | $917M | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B |
| Margins | ||||||||||
| Gross margin | 56.0% | 51.5% | 48.2% | 48.7% | 63.1% | 84.8% | 64.4% | 58.1% | 57.5% | 58.1% |
| Operating margin | 16.3% | 15.9% | 18.0% | 21.1% | 33.0% | 34.2% | 22.1% | 19.9% | 22.0% | 23.5% |
| EBITDA margin | 18.4% | 17.8% | 19.5% | 22.4% | 34.8% | 37.1% | 24.2% | 21.7% | 23.5% | 24.8% |
| Net margin | 4.6% | 4.0% | 7.2% | 3.1% | 34.9% | 21.2% | 11.9% | 8.3% | 7.9% | 9.8% |
| FCF margin | 50.8% | 59.3% | 68.9% | 70.5% | 65.6% | 36.6% | 49.0% | 53.0% | 56.3% | 56.2% |
| Net interest share of revenue | β8.8% | β10.2% | β8.2% | β6.4% | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 9.3% | 10.2% | 13.8% | 14.0% | 19.8% | 13.6% | 8.7% | 7.9% | 9.6% | 9.9% |
| Return on equity | 14.3% | 11.2% | 22.3% | 10.1% | 58.4% | 25.5% | 18.2% | 14.4% | 17.2% | 24.3% |
| Return on assets | 3.5% | 2.7% | 5.6% | 2.5% | 20.5% | 10.5% | 6.3% | 4.2% | 4.3% | 5.3% |
| Return on tangible equity | β | 282.6% | 90.4% | 34.1% | 60.6% | 32.9% | 23.6% | 18.6% | 23.1% | 29.3% |
| Growth | ||||||||||
| Revenue growth | β | β2.2% | 33.4% | 20.8% | β7.8% | 11.5% | 43.7% | 22.0% | 25.5% | 18.6% |
| Net income growth | β | β15.5% | 139.7% | β47.8% | 932.0% | β32.2% | β19.1% | β15.6% | 19.6% | 47.2% |
| EPS growth | β | β16.5% | 131.4% | β46.7% | 1,003.8% | β42.0% | β8.8% | β11.3% | 35.3% | 55.0% |
| FCF growth | β | 14.0% | 55.2% | 23.6% | β14.1% | β37.8% | 92.3% | 31.9% | 33.3% | 18.5% |
| Share count change | β | 2.0% | 3.1% | β2.2% | β6.1% | 16.8% | β11.3% | β4.7% | β11.7% | β5.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.5x | 5.7x | 4.4x | 3.6x | 1.7x | 2.7x | 5.1x | 6.3x | 5.6x | 5.7x |
| Debt / equity | 2.7x | 2.8x | 2.5x | 2.6x | 1.0x | 1.3x | 1.9x | 2.4x | 3.0x | 3.4x |
| Interest coverage | β | β | 2.2x | 3.3x | 4.1x | 5.4x | 3.3x | 2.2x | 2.0x | 2.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 2.1% | 1.5% | 1.7% | 2.7% | 2.5% | 2.5% | 2.1% | 1.6% | 1.5% |
| Stock comp / revenue | 1.1% | 1.6% | 1.2% | 1.0% | 1.7% | 1.8% | 1.3% | 1.3% | 1.2% | 1.1% |
| Payouts / FCF | 0.1% | 1.2% | 2.6% | 4.1% | 7.9% | 26.4% | 16.8% | 13.7% | 19.3% | 12.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 6.0 | 7.0 | 7.0 | 4.0 | 5.0 | 5.0 | 6.0 | 6.0 |
| Accruals ratio | β36.7% | β39.1% | β49.3% | β55.8% | β19.7% | β8.9% | β21.0% | β23.7% | β27.0% | β25.7% |
Source: SEC EDGAR XBRL filings (CIK 0001529864). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
